News
Shattuck made the difficult but appropriate decision to terminate our SL-172154 program in 2024, and rapidly transitioned to our potential ...
Target engagement increased in a dose-dependent manner, with CD47 receptor occupancy ranging up to 100% at the highest doses evaluated. ACC Abstract Details The poster presentation will be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results